Zuñiga-Ramos, Joaquin Alejandro

academic article in scopus

• Mexico¿s Laboratory-Confirmed Human Case of Infection with the Influenza A(H5N2) Virus.  Viruses.  2025
• Vaccination with Plasmids Encoding the Fusion Proteins D-S1, D-S1N and O-SN from SARS-CoV-2 Induces an Effective Humoral and Cellular Immune Response in Mice.  Vaccines.  2025
• PDGFRa-positive cell-derived TIMP-1 modulates adaptive immune responses to influenza A viral infection.  American Journal of Physiology - Lung Cellular and Molecular Physiology.  2025
• SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1.  Cancer Gene Therapy.  2025
• The impact of circulating nucleosomes on inflammation in acute lung injury.  FASEB Journal.  2024
• Estrogen-dependent gene regulation: Molecular basis of TIMP-1 as a sex-specific biomarker for acute lung injury.  Physiological Reports.  2024
• Club Cell Secretory Protein-16 (CC16) as a Prognostic Biomarker for COVID-19 and H1N1 Viral Infections.  Diagnostics.  2024
• Development of Luminescent Biosensors for Calprotectin.  ACS Chemical Biology.  2024
• Microbiome in the nasopharynx: Insights into the impact of COVID-19 severity.  Heliyon.  2024
• The rs11684747 and rs55790676 SNPs of ADAM17 influence tuberculosis susceptibility and plasma levels of TNF, TNFR1, and TNFR2.  Frontiers in Microbiology.  2024
• A second update on mapping the human genetic architecture of COVID-19.  Nature.  2023
• Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.  Immunity.  2023
• Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production.  Journal of Clinical Investigation.  2023
• Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis.  Rheumatology.  62:1687-1698. 2023
• Combination of Recombinant Proteins S1/N and RBD/N as Potential Vaccine Candidates.  Vaccines.  11. 2023
• Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control.  Nature Immunology.  24:855-868. 2023
• CD4+ T Cell Regulatory Network Underlies the Decrease in Th1 and the Increase in Anergic and Th17 Subsets in Severe COVID-19.  Pathogens.  12. 2023
• Molecular transition of SARS-CoV-2 from critical patients during the first year of the COVID-19 pandemic in Mexico City.  Frontiers in Cellular and Infection Microbiology.  13. 2023
• Salivette® Cortisol versus oropharyngeal swabbing for the detection of SARS-CoV-2 infection.  Expert Review of Molecular Diagnostics.  2023
• Winds of change a tale of: asthma and microbiome.  Frontiers in Microbiology.  2023
• Association of the Transmembrane Serine Protease-2 (TMPRSS2) Polymorphisms with COVID-19.  Viruses.  14. 2022
• Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza.  Journal of Interferon and Cytokine Research.  42:369-392. 2022
• Differential Leukocyte Expression of IFITM1 and IFITM3 in Patients with Severe Pandemic Influenza A(H1N1) and COVID-19.  Journal of Interferon and Cytokine Research.  42:430-443. 2022
• Friendly Fire in the War Against Pathogens: On the Harmful Effects of Cytokines and the Origins of Cytokine Storms in Infectious Diseases.  Journal of Interferon and Cytokine Research.  42:349-351. 2022
• Possible Role of Matrix Metalloproteinases and TGF-ß in COVID-19 Severity and Sequelae.  Journal of Interferon and Cytokine Research.  42:352-368. 2022
• Cyclic Attractors Are Critical for Macrophage Differentiation, Heterogeneity, and Plasticity.  Frontiers in Molecular Biosciences.  9. 2022
• A(H3N2) antigenic variation of influenza is associated with low vaccine efficacy in the early 2018 influenza season in Mexico City.  International Journal of Infectious Diseases.  125:114-119. 2022
• Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer.  European Journal of Cancer.  160:189-205. 2022
• CXCL17 Is Dispensable during Hypervirulent Mycobacterium tuberculosis HN878 Infection in Mice.  ImmunoHorizons.  5:752-759. 2021
• Comprehensive immunologic evaluation of bronchoalveolar lavage samples from human patients with moderate and severe seasonal influenza and severe covid-19.  Journal of Immunology.  207:1229-1238. 2021
• Clinical Risk Factors for Mortality Among Critically Ill Mexican Patients With COVID-19.  Frontiers in Medicine.  8. 2021
• Heterogeneity of Genetic Admixture Determines SLE Susceptibility in Mexican.  Frontiers in Genetics.  12. 2021
• Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019.  Journal of Infectious Diseases.  224:21-30. 2021
• Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297).  Frontiers in Immunology.  12. 2021
• Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).  Frontiers in Immunology.  12. 2021
• CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.  Frontiers in Immunology.  12. 2021
• Experimental Tracheal Replacement: Angiogenesis and Null Apoptosis Promote Stenosis.  Journal of Chest Surgery.  54:191-199. 2021
• Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity.  Journal of Immunology Research.  2021. 2021
• Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis.  Journal of Immunology Research.  2021. 2021
• Radiation-induced PEGylated ethambutol has low antimycobacterial activity in vitro.  Biointerface Research in Applied Chemistry.  11:8884-8894. 2021
• The immune landscape in tuberculosis reveals populations linked to disease and latency.  Cell Host and Microbe.  29:165-178.e8. 2021
• Diversity of HLA Class I and Class II blocks and conserved extended haplotypes in Lacandon Mayans.  Scientific Reports.  10. 2020
• Impaired cellular immune responses during the first week of severe acute influenza infection.  Journal of Infectious Diseases.  222:1235-1244. 2020
• Antigens of Mycobacterium tuberculosis Stimulate CXCR6+ Natural Killer Cells.  Frontiers in Immunology.  11. 2020
• Genetic diversity of HLA system in a population from Guerrero, Mexico.  Human Immunology.  81:550-552. 2020
• Genetic diversity of HLA system in a population sample from Aguascalientes, Mexico.  Human Immunology.  81:519-521. 2020
• Genetic diversity of HLA system in four populations from Baja California, Mexico: Mexicali, La Paz, Tijuana and rural Baja California.  Human Immunology.  81:475-477. 2020
• Genetic diversity of HLA system in seven populations from Veracruz, Mexico: Veracruz city, Coatzacoalcos, Córdoba, Orizaba, Poza Rica, Xalapa and rural Veracruz.  Human Immunology.  81:531-534. 2020
• Genetic diversity of HLA system in six populations from Jalisco, Mexico: Guadalajara city, Tlajomulco, Tlaquepaque, Tonalá, Zapopan and rural Jalisco.  Human Immunology.  81:502-505. 2020
• Genetic diversity of HLA system in six populations from Mexico City Metropolitan Area, Mexico: Mexico City North, Mexico City South, Mexico City East, Mexico City West, Mexico City Center and rural Mexico City.  Human Immunology.  81:539-543. 2020
• Genetic diversity of HLA system in three populations from Chihuahua, Mexico: Chihuahua City, Ciudad Juárez and rural Chihuahua.  Human Immunology.  81:485-488. 2020
• Genetic diversity of HLA system in three populations from Coahuila, Mexico: Torreón, Saltillo and rural Coahuila.  Human Immunology.  81:492-495. 2020
• Genetic diversity of HLA system in three populations from Guanajuato, Mexico: Guanajuato City, León and rural Guanajuato.  Human Immunology.  81:510-512. 2020
• Genetic diversity of HLA system in three populations from Sonora, Mexico: Ciudad Obregón, Hermosillo and rural Sonora.  Human Immunology.  81:478-481. 2020
• Genetic diversity of HLA system in three populations from Zacatecas, Mexico: Zacatecas city, Fresnillo and rural Zacatecas.  Human Immunology.  81:496-498. 2020
• Genetic diversity of HLA system in two populations from Campeche, Mexico: Campeche city and rural Campeche.  Human Immunology.  81:566-568. 2020
• Genetic diversity of HLA system in two populations from Chiapas, Mexico: Tuxtla Gutiérrez and rural Chiapas.  Human Immunology.  81:563-565. 2020
• Genetic diversity of HLA system in two populations from Colima, Mexico: Colima city and rural Colima.  Human Immunology.  81:513-515. 2020
• Genetic diversity of HLA system in two populations from Durango, Mexico: Durango city and rural Durango.  Human Immunology.  81:489-491. 2020
• Genetic diversity of HLA system in two populations from Hidalgo, Mexico: Pachuca and rural Hidalgo.  Human Immunology.  81:535-538. 2020
• Genetic diversity of HLA system in two populations from Michoacán, Mexico: Morelia and rural Michoacán.  Human Immunology.  81:506-509. 2020
• Genetic diversity of HLA system in two populations from Morelos, Mexico: Cuernavaca and rural Morelos.  Human Immunology.  81:557-559. 2020
• Genetic diversity of HLA system in two populations from Nayarit, Mexico: Tepic and rural Nayarit.  Human Immunology.  81:499-501. 2020
• Genetic diversity of HLA system in two populations from Nuevo León, Mexico: Monterrey and rural Nuevo León.  Human Immunology.  81:516-518. 2020
• Genetic diversity of HLA system in two populations from Oaxaca, Mexico: Oaxaca city and rural Oaxaca.  Human Immunology.  81:553-556. 2020
• Genetic diversity of HLA system in two populations from Puebla, Mexico: Puebla city and rural Puebla.  Human Immunology.  81:547-549. 2020
• Genetic diversity of HLA system in two populations from Querétaro, Mexico: Querétaro city and rural Querétaro.  Human Immunology.  81:522-524. 2020
• Genetic diversity of HLA system in two populations from Quintana Roo, Mexico: Cancún and rural Quintana Roo.  Human Immunology.  81:573-575. 2020
• Genetic diversity of HLA system in two populations from San Luis Potosí, Mexico: San Luis Potosí City and rural San Luis Potosí.  Human Immunology.  81:528-530. 2020
• Genetic diversity of HLA system in two populations from Sinaloa, Mexico: Culiacán and rural Sinaloa.  Human Immunology.  81:482-484. 2020
• Genetic diversity of HLA system in two populations from Tabasco, Mexico: Villahermosa and rural Tabasco.  Human Immunology.  81:560-562. 2020
• Genetic diversity of HLA system in two populations from Tamaulipas, Mexico: Ciudad Victoria and rural Tamaulipas.  Human Immunology.  81:525-527. 2020
• Genetic diversity of HLA system in two populations from Tlaxcala, Mexico: Tlaxcala city and rural Tlaxcala.  Human Immunology.  81:544-546. 2020
• Genetic diversity of HLA system in two populations from Yucatán, Mexico: Mérida and rural Yucatán.  Human Immunology.  81:569-572. 2020
• The immunogenetic diversity of the HLA system in Mexico correlates with underlying population genetic structure.  Human Immunology.  81:461-474. 2020
• Esophagogastric junction outflow obstruction: Characterization of a new entity? Clinical, manometric, and neuroimmunological description.  Neurogastroenterology and Motility.  32. 2020
• The role of socioeconomic status in the susceptibility to develop systemic lupus erythematosus in Mexican patients.  Clinical Rheumatology.  39:2151-2161. 2020
• Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): A study protocol of a prospective multicentre cohort study.  BMJ Open.  10. 2020
• S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis.  Journal of Clinical Investigation.  130:3098-3112. 2020
• The protective and pathogenic roles of CXCL17 in human health and disease: Potential in respiratory medicine.  Cytokine and Growth Factor Reviews.  53:53-62. 2020
• A unique immune signature of serum cytokine and chemokine dynamics in patients with Zika virus infection from a tropical region in Southern Mexico.  International Journal of Infectious Diseases.  94:4-11. 2020
• Thinking Outside the Box: Innate- and B Cell-Memory Responses as Novel Protective Mechanisms Against Tuberculosis.  Frontiers in Immunology.  11. 2020
• High performance of rapid influenza diagnostic test and variable effectiveness of influenza vaccines in Mexico.  International Journal of Infectious Diseases.  89:87-95. 2019
• Synthesis, characterization, and in vitro evaluation of gamma radiation-induced PEGylated isoniazid.  Electronic Journal of Biotechnology.  41:81-87. 2019
• Publisher Correction: Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis (Nature, (2019), 570, 7762, (528-532), 10.1038/s41586-019-1276-2).  Nature.  572:E10. 2019
• Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.  Cytokine.  119:95-112. 2019
• Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.  Nature.  570:528-532. 2019
• Dysregulated expression of hypoxia-inducible factors augments myofibroblasts differentiation in idiopathic pulmonary fibrosis.  Respiratory Research.  20:130. 2019
• Epigenetics in non-small cell lung carcinomas.  Salud Publica de Mexico.  61:318-328. 2019
• MicroRNA Expression in Cutaneous Lupus: A New Window to Understand Its Pathogenesis.  Mediators of Inflammation.  2019. 2019
• Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.  JCI insight.  3. 2018
• An original Eurasian haplotype, HLA-DRB114:54-DQB105:03, influences the susceptibility to idiopathic achalasia.  PLoS ONE.  13. 2018
• Synthesis of gamma radiation-induced PEGylated cisplatin for cancer treatment.  RSC Advances.  8:34718-34725. 2018